Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIRU | US
-0.00
-6.67%
Healthcare
Biotechnology
30/06/2024
02/06/2026
0.00
0.00
0.00
0.00
Hiru Corporation through its subsidiary produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng. The company sells and distributes pharmaceuticals health and beauty products dietary and herbal supplements and other healthcare products. It manufactures approximately 120 extracts used in traditional Chinese medicine. Hiru Corporation sells its products through regional distributors as well as directly to the hospitals clinics and pharmacies in China. Hiru Corporation was formerly known as Phoenix Restaurant Group Inc. and changed its name to Hiru Corporation in November 2008. The company is based in Phoenix Arizona.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
79.5%1 month
99.0%3 months
198.6%6 months
185.2%-
-
-
2.63
0.71
-0.07
0.01
-
5.92M
2.65M
2.65M
-
8.99
-
-
19.68
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.00
Range1M
0.00
Range3M
0.00
Rel. volume
0.42
Price X volume
6.75K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals Inc. Common Stock | SXTP | Biotechnology | 1.47 | 2.74M | 0.68% | n/a | 5.19% |
| PALISADE BIO INC | PALI | Biotechnology | 1.86 | 2.58M | -10.58% | n/a | 5.06% |
| BioRestorative Therapies Inc | BRTX | Biotechnology | 0.3544 | 2.45M | -12.80% | n/a | 0.77% |
| Allarity Therapeutics Inc. Common Stock | ALLR | Biotechnology | 1.69 | 2.39M | -1.74% | n/a | 6.68% |
| Orgenesis Inc | ORGS | Biotechnology | 0.495 | 2.36M | 4850.00% | n/a | -84.02% |
| Vaccinex Inc - Ordinary Shares | VCNX | Biotechnology | 0.8 | 2.08M | 5.11% | n/a | -4.26% |
| Dermata Therapeutics Inc. Common Stock | DRMA | Biotechnology | 1.36 | 2.05M | 1.49% | n/a | 0.00% |
| Biodexa Pharmaceticals | BDRX | Biotechnology | 3.5 | 2.03M | 5.42% | n/a | 0.00% |
| Genprex Inc | GNPX | Biotechnology | 0.7352 | 1.90M | -1.99% | n/a | 0.00% |
| Soligenix Inc | SNGX | Biotechnology | 0.7488 | 1.71M | -9.27% | n/a | 84.28% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.07 | - | Cheaper |
| Ent. to Revenue | 0.01 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 198.64 | - | Riskier |
| Debt to Equity | 2.63 | -1.23 | Expensive |
| Debt to Assets | 0.71 | 0.25 | Expensive |
| Market Cap | 2.65M | - | Emerging |